DISOPYRAMIDE PHOSPHATE

DISOPYRAMIDE PHOSPHATE was reported 853 times

DISOPYRAMIDE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ILEAL GANGRENE 1 0.1000
1 STENT EMBOLISATION 1 0.0588
2 ANTICHOLINERGIC EFFECT 2 0.0267
3 TRANSVALVULAR PRESSURE GRADIENT INCREASED 1 0.0233
4 CASTLEMAN'S DISEASE 1 0.0172
5 ERYTHROLEUKAEMIA 1 0.0132
6 GLOSSOPTOSIS 2 0.0091
7 ECHOCARDIOGRAM 1 0.0079
8 LOSS OF DREAMING 1 0.0075
9 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 1 0.0068
10 PERINEAL INJURY 1 0.0066
11 INFUSION SITE INJURY 1 0.0057
12 POOR WEIGHT GAIN NEONATAL 1 0.0051
13 OROPHARYNGITIS FUNGAL 1 0.0050
14 BURN INFECTION 1 0.0049
15 GLOBAL AMNESIA 1 0.0047
16 ARTERIAL REPAIR 1 0.0046
17 GINGIVAL BLISTER 2 0.0046
18 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
19 ILIOTIBIAL BAND SYNDROME 1 0.0044
20 NASAL ABSCESS 1 0.0043
21 LEFT VENTRICULAR ENLARGEMENT 1 0.0039
22 LEFT ATRIAL ENLARGEMENT 2 0.0037
23 VOCAL CORD POLYP 1 0.0035
24 OMPHALITIS 1 0.0035
25 SUBCUTANEOUS NODULE 1 0.0035
26 GASTROINTESTINAL ARTERIOVENOUS MALFORMATION 1 0.0034
27 LUNG INJURY 1 0.0033
28 INCISION SITE SWELLING 1 0.0033
29 CAUSTIC INJURY 1 0.0032
30 TONGUE SPASM 1 0.0032
31 RHYTHM IDIOVENTRICULAR 1 0.0031
32 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
33 VASCULAR DEVICE OCCLUSION 1 0.0029
34 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
35 BRUGADA SYNDROME 3 0.0029
36 FAT EMBOLISM 1 0.0028
37 HYPOGLYCAEMIA UNAWARENESS 1 0.0028
38 HEART VALVE STENOSIS 1 0.0028
39 COLOUR BLINDNESS ACQUIRED 1 0.0028
40 SMALL FIBRE NEUROPATHY 2 0.0027
41 VIRAL MYOCARDITIS 1 0.0027
42 CAROTID BRUIT 1 0.0026
43 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 1 0.0026
44 MYOCARDIAL OEDEMA 1 0.0025
45 OBSTRUCTIVE UROPATHY 1 0.0025
46 URETHRAL OBSTRUCTION 1 0.0025
47 CARDIAC VENTRICULAR DISORDER 1 0.0024
48 INFUSION SITE SCAR 1 0.0023
49 HEPATIC ATROPHY 1 0.0022
50 TOOTH IMPACTED 1 0.0022
51 MANUFACTURING ISSUE 1 0.0022
52 BIOPSY BONE MARROW 1 0.0021
53 SKIN FIBROSIS 1 0.0021
54 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
55 DIABETES MELLITUS INSULIN-DEPENDENT 1 0.0020
56 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
57 TRACHEAL DISORDER 1 0.0019
58 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
59 DRUG LEVEL ABNORMAL 1 0.0019
60 PRODUCT NAME CONFUSION 2 0.0018
61 URINE COLOUR ABNORMAL 1 0.0018
62 THORACIC VERTEBRAL FRACTURE 5 0.0017
63 LIP DISCOLOURATION 2 0.0016
64 SCLERAL DISCOLOURATION 1 0.0015
65 SPUTUM ABNORMAL 1 0.0015
66 THROAT LESION 1 0.0015
67 GRAVITATIONAL OEDEMA 1 0.0014
68 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
69 MYOFASCIAL PAIN SYNDROME 1 0.0014
70 CEREBELLAR HAEMORRHAGE 2 0.0014
71 DYSLALIA 1 0.0014
72 NODAL RHYTHM 2 0.0014
73 AORTIC VALVE SCLEROSIS 1 0.0014
74 LEGAL PROBLEM 1 0.0014
75 GINGIVAL ULCERATION 1 0.0013
76 VIOLENCE-RELATED SYMPTOM 2 0.0013
77 INJECTION SITE BURNING 1 0.0013
78 INCISION SITE HAEMORRHAGE 1 0.0012
79 ACCIDENTAL NEEDLE STICK 1 0.0012
80 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
81 SCIATIC NERVE INJURY 1 0.0012
82 DEVICE LOOSENING 1 0.0012
83 AXONAL NEUROPATHY 1 0.0011
84 ARTERIAL STENOSIS 1 0.0011
85 MITRAL VALVE DISEASE 2 0.0011
86 VOCAL CORD PARALYSIS 2 0.0011
87 HYPERPLASIA 1 0.0011
88 EXTENSOR PLANTAR RESPONSE 1 0.0011
89 VENOUS INJURY 1 0.0011
90 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
91 RAYNAUD'S PHENOMENON 1 0.0011
92 ELECTROCARDIOGRAM CHANGE 1 0.0011
93 PRODUCT AFTER TASTE 1 0.0010
94 HYPOGLYCAEMIC COMA 3 0.0010
95 HYPOCOAGULABLE STATE 1 0.0010
96 HYPOGONADISM 1 0.0010
97 BURNS THIRD DEGREE 1 0.0009
98 ALLERGY TO ANIMAL 1 0.0009
99 JOINT CONTRACTURE 1 0.0009
100 AORTIC DILATATION 1 0.0009
101 CLEFT LIP AND PALATE 1 0.0009
102 PRURITUS ALLERGIC 1 0.0009
103 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
104 URINARY HESITATION 2 0.0008
105 LONG QT SYNDROME 2 0.0008
106 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
107 VENTRICULAR ARRHYTHMIA 3 0.0008
108 LARGE INTESTINE INFECTION 1 0.0008
109 INTERVERTEBRAL DISC OPERATION 1 0.0008
110 VENTRICULAR HYPERTROPHY 2 0.0008
111 NEPHRITIS INTERSTITIAL 1 0.0008
112 LEFT ATRIAL DILATATION 1 0.0008
113 NOCTURNAL DYSPNOEA 1 0.0008
114 ASPERGILLOSIS 1 0.0008
115 TORSADE DE POINTES 6 0.0008
116 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
117 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
118 CARDIOVERSION 1 0.0007
119 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
120 ENDOTRACHEAL INTUBATION 2 0.0007
121 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
122 HEPATITIS FULMINANT 2 0.0007
123 KNEE DEFORMITY 1 0.0007
124 HEARING IMPAIRED 4 0.0007
125 VENTRICULAR TACHYCARDIA 11 0.0007
126 HEART RATE IRREGULAR 15 0.0007
127 ADHESION 1 0.0007
128 ORAL MUCOSAL EXFOLIATION 1 0.0007
129 MOUTH INJURY 1 0.0007
130 ORAL MUCOSAL ERUPTION 1 0.0007
131 SINUS ARREST 1 0.0006
132 ANTICHOLINERGIC SYNDROME 1 0.0006
133 NASAL ULCER 1 0.0006
134 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
135 OPTIC NERVE DISORDER 1 0.0006
136 CYSTITIS INTERSTITIAL 1 0.0006
137 POSTURE ABNORMAL 2 0.0006
138 ILLUSION 1 0.0006
139 RESUSCITATION 1 0.0006
140 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
141 MITRAL VALVE PROLAPSE 1 0.0006
142 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
143 ENTERITIS INFECTIOUS 1 0.0006
144 VENTRICULAR EXTRASYSTOLES 6 0.0006
145 EXTRASYSTOLES 4 0.0006
146 CAROTID ARTERY STENOSIS 2 0.0006
147 INFUSION SITE DISCHARGE 1 0.0006
148 JUGULAR VEIN THROMBOSIS 1 0.0006
149 CARDIAC ABLATION 1 0.0006
150 NO ADVERSE EFFECT 1 0.0006
151 CONDUCTION DISORDER 1 0.0005
152 HEART RATE ABNORMAL 3 0.0005
153 SNORING 2 0.0005
154 ADRENAL DISORDER 1 0.0005
155 HYPERVENTILATION 3 0.0005
156 EARLY SATIETY 1 0.0005
157 CERVIX CARCINOMA 2 0.0005
158 URINE ODOUR ABNORMAL 3 0.0005
159 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
160 ATRIAL FLUTTER 4 0.0005
161 MUCOSAL DRYNESS 1 0.0005
162 EAR HAEMORRHAGE 1 0.0005
163 LIBIDO INCREASED 1 0.0005
164 ATRIAL FIBRILLATION 48 0.0005
165 SKIN INDURATION 1 0.0005
166 WALKING DISABILITY 1 0.0005
167 NEUROGENIC BLADDER 1 0.0005
168 CARDIOMYOPATHY 7 0.0005
169 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
170 AORTIC VALVE INCOMPETENCE 2 0.0005
171 BLOOD TESTOSTERONE INCREASED 1 0.0005
172 FACIAL PALSY 1 0.0005
173 EXPOSED BONE IN JAW 1 0.0005
174 PRODUCT DISPENSING ERROR 10 0.0005
175 TONGUE DISCOLOURATION 2 0.0005
176 NOSOCOMIAL INFECTION 1 0.0005
177 BLOOD CREATINE INCREASED 2 0.0005
178 GASTROINTESTINAL ULCER 1 0.0005
179 PARESIS 1 0.0004
180 CALCINOSIS 1 0.0004
181 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
182 FLAT AFFECT 1 0.0004
183 DISCOURAGEMENT 1 0.0004
184 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
185 PAINFUL RESPIRATION 1 0.0004
186 SINUS BRADYCARDIA 4 0.0004
187 PANNICULITIS 1 0.0004
188 HAEMATOLOGICAL INFECTION 1 0.0004
189 BREATH SOUNDS ABNORMAL 2 0.0004
190 RETROPERITONEAL HAEMORRHAGE 1 0.0004
191 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
192 DEVICE INFUSION ISSUE 1 0.0004
193 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
194 APPENDICITIS PERFORATED 1 0.0004
195 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
196 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
197 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
198 ANGIONEUROTIC OEDEMA 1 0.0004
199 ALCOHOL POISONING 1 0.0004
200 STENT PLACEMENT 3 0.0004
201 CHONDROPATHY 1 0.0004
202 SUBDURAL HAEMORRHAGE 1 0.0004
203 JAW DISORDER 2 0.0004
204 VITREOUS HAEMORRHAGE 1 0.0004
205 VENTRICULAR FIBRILLATION 4 0.0004
206 THERAPEUTIC RESPONSE DELAYED 1 0.0004
207 SKIN HYPERTROPHY 1 0.0004
208 OXYGEN SATURATION ABNORMAL 1 0.0004
209 INJECTION SITE SCAR 1 0.0004
210 CARDIAC VALVE DISEASE 2 0.0003
211 CARDIAC MURMUR 3 0.0003
212 STRESS CARDIOMYOPATHY 2 0.0003
213 GASTROINTESTINAL NECROSIS 1 0.0003
214 BLOOD CALCIUM INCREASED 3 0.0003
215 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
216 MACULAR DEGENERATION 4 0.0003
217 URINE ANALYSIS ABNORMAL 1 0.0003
218 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
219 EMBOLISM VENOUS 1 0.0003
220 CHEST X-RAY ABNORMAL 1 0.0003
221 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
222 FIBROSIS 1 0.0003
223 DIASTOLIC DYSFUNCTION 1 0.0003
224 FAMILY STRESS 1 0.0003
225 SWELLING OF EYELID 2 0.0003
226 EOSINOPHILIC PNEUMONIA 1 0.0003
227 SLEEP APNOEA SYNDROME 6 0.0003
228 VENTRICULAR HYPOKINESIA 1 0.0003
229 LIVER ABSCESS 1 0.0003
230 HEPATITIS ACUTE 2 0.0003
231 DRUG EFFECT INCOMPLETE 11 0.0003
232 OTITIS MEDIA 1 0.0003
233 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
234 BLOOD PRESSURE ABNORMAL 6 0.0003
235 URINARY RETENTION 10 0.0003
236 POTENTIATING DRUG INTERACTION 1 0.0003
237 WOUND DEHISCENCE 1 0.0003
238 SLUGGISHNESS 3 0.0003
239 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
240 LEFT VENTRICULAR FAILURE 1 0.0003
241 MICTURITION DISORDER 1 0.0003
242 CEREBRAL INFARCTION 7 0.0003
243 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
244 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
245 CONJUNCTIVAL HYPERAEMIA 1 0.0003
246 APPENDICECTOMY 1 0.0003
247 APPARENT DEATH 1 0.0003
248 SCLERODERMA 1 0.0003
249 LIVER TRANSPLANT 1 0.0003
250 PALPITATIONS 32 0.0003
251 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
252 FACE INJURY 1 0.0003
253 DRUG DISPENSING ERROR 4 0.0003
254 GASTRIC INFECTION 1 0.0003
255 GINGIVAL DISORDER 1 0.0003
256 CARDIOPULMONARY FAILURE 1 0.0003
257 EPIGASTRIC DISCOMFORT 1 0.0003
258 SKIN ODOUR ABNORMAL 1 0.0003
259 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
260 ARRHYTHMIA 12 0.0003
261 RENAL CYST 2 0.0003
262 SCIATICA 4 0.0003
263 HYPERPHAGIA 1 0.0003
264 POLYNEUROPATHY 3 0.0003
265 OBSTRUCTION 1 0.0003
266 BLOOD DISORDER 2 0.0002
267 SPINAL FRACTURE 5 0.0002
268 ARTERIOSPASM CORONARY 1 0.0002
269 INTRACRANIAL ANEURYSM 1 0.0002
270 MYASTHENIA GRAVIS 2 0.0002
271 HYPOGLYCAEMIA 12 0.0002
272 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
273 DRY MOUTH 20 0.0002
274 APPLICATION SITE DISCOLOURATION 1 0.0002
275 POST PROCEDURAL INFECTION 2 0.0002
276 BRADYCARDIA 13 0.0002
277 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
278 THYROID FUNCTION TEST ABNORMAL 1 0.0002
279 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
280 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
281 HEPATIC PAIN 1 0.0002
282 ROTATOR CUFF SYNDROME 3 0.0002
283 SKIN HYPERPIGMENTATION 2 0.0002
284 CARDIAC OPERATION 2 0.0002
285 TEARFULNESS 1 0.0002
286 TOOTH INJURY 1 0.0002
287 HEART RATE DECREASED 8 0.0002
288 WRONG DRUG ADMINISTERED 2 0.0002
289 SUSPECTED OFF LABEL USE 1 0.0002
290 DRUG EFFECT DELAYED 1 0.0002
291 VASCULAR DEVICE INFECTION 1 0.0002
292 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
293 CORONARY ARTERY OCCLUSION 3 0.0002
294 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
295 ISCHAEMIA 1 0.0002
296 EYE OPERATION 1 0.0002
297 ARTHRITIS INFECTIVE 1 0.0002
298 HEPATIC ENCEPHALOPATHY 2 0.0002
299 VAGINAL INFECTION 1 0.0002
300 SKIN ABRASION 1 0.0002
301 PULSE ABSENT 1 0.0002
302 CARDIOGENIC SHOCK 3 0.0002
303 HYPOVOLAEMIC SHOCK 1 0.0002
304 LIMB OPERATION 1 0.0002
305 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
306 EXPIRED DRUG ADMINISTERED 1 0.0002
307 MULTIPLE DRUG OVERDOSE 1 0.0002
308 FLUID INTAKE REDUCED 1 0.0002
309 CORONARY ARTERY DISEASE 6 0.0002
310 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
311 DYSLIPIDAEMIA 1 0.0002
312 INSURANCE ISSUE 3 0.0002
313 AMMONIA INCREASED 1 0.0002
314 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
315 PERIPHERAL VASCULAR DISORDER 1 0.0002
316 EJECTION FRACTION DECREASED 3 0.0002
317 TONSILLITIS 1 0.0002
318 MALABSORPTION 1 0.0002
319 BODY HEIGHT DECREASED 2 0.0002
320 HIP FRACTURE 6 0.0002
321 GINGIVITIS 1 0.0002
322 CHEILITIS 1 0.0002
323 ERYTHEMA OF EYELID 1 0.0002
324 PROSTATIC DISORDER 1 0.0002
325 DENTAL CARIES 2 0.0002
326 CYSTIC FIBROSIS 1 0.0002
327 NECROSIS 1 0.0002
328 PRODUCT LEAKAGE 1 0.0002
329 ACUTE PULMONARY OEDEMA 1 0.0002
330 OCULAR DISCOMFORT 2 0.0002
331 MITRAL VALVE INCOMPETENCE 2 0.0002
332 SHOCK 4 0.0002
333 HERPES VIRUS INFECTION 1 0.0002
334 ENTEROCOLITIS 1 0.0002
335 LOSS OF CONSCIOUSNESS 22 0.0002
336 HYPERTRIGLYCERIDAEMIA 1 0.0002
337 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
338 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
339 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
340 CATARACT OPERATION 1 0.0002
341 PLEURISY 1 0.0002
342 CARDIAC PACEMAKER INSERTION 1 0.0002
343 MYOCLONUS 2 0.0002
344 HYPERLIPIDAEMIA 2 0.0002
345 GOUT 3 0.0002
346 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
347 OSTEOMYELITIS 3 0.0002
348 BLOOD PRESSURE DECREASED 11 0.0002
349 INGUINAL HERNIA 1 0.0002
350 DYSURIA 6 0.0002
351 MENISCUS INJURY 1 0.0002
352 HEART RATE INCREASED 16 0.0002
353 FEMUR FRACTURE 5 0.0002
354 OLIGURIA 1 0.0002
355 THINKING ABNORMAL 3 0.0002
356 PHOTOPSIA 1 0.0002
357 BLOOD URINE PRESENT 3 0.0002
358 FOREIGN BODY SENSATION IN EYES 1 0.0002
359 ANOREXIA 2 0.0002
360 HAEMATOMA 4 0.0002
361 APPLICATION SITE VESICLES 1 0.0002
362 HAEMORRHOIDS 3 0.0002
363 EYE DISORDER 5 0.0002
364 DYSGRAPHIA 1 0.0002
365 TOOTH INFECTION 2 0.0002
366 APPETITE DISORDER 1 0.0002
367 BLOOD CHOLESTEROL INCREASED 7 0.0002
368 CARDIAC FAILURE ACUTE 1 0.0001
369 SYNCOPE 15 0.0001
370 SKIN MASS 1 0.0001
371 INTENTIONAL PRODUCT MISUSE 13 0.0001
372 BRONCHIECTASIS 1 0.0001
373 WRONG PRODUCT ADMINISTERED 1 0.0001
374 ULCER HAEMORRHAGE 1 0.0001
375 BLOOD TESTOSTERONE DECREASED 1 0.0001
376 INFARCTION 1 0.0001
377 RESPIRATION ABNORMAL 1 0.0001
378 DRUG INTERACTION 23 0.0001
379 ORAL DISCOMFORT 2 0.0001
380 RHABDOMYOLYSIS 6 0.0001
381 THERMAL BURN 1 0.0001
382 DIVERTICULUM 1 0.0001
383 RETINAL HAEMORRHAGE 1 0.0001
384 FEAR OF INJECTION 1 0.0001
385 PRODUCT SUPPLY ISSUE 1 0.0001
386 HYPOACUSIS 6 0.0001
387 CARDIAC DISORDER 13 0.0001
388 PARAESTHESIA ORAL 2 0.0001
389 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
390 VISUAL FIELD DEFECT 1 0.0001
391 DYSSTASIA 4 0.0001
392 BLINDNESS TRANSIENT 1 0.0001
393 ARTHROPOD BITE 1 0.0001
394 NERVOUSNESS 7 0.0001
395 HEPATIC FUNCTION ABNORMAL 5 0.0001
396 DYSPNOEA EXERTIONAL 5 0.0001
397 PAROSMIA 1 0.0001
398 PEMPHIGOID 1 0.0001
399 ECONOMIC PROBLEM 2 0.0001
400 SKIN DISCOLOURATION 6 0.0001
401 RENAL FAILURE CHRONIC 1 0.0001
402 PHARYNGEAL OEDEMA 2 0.0001
403 THYROID DISORDER 2 0.0001
404 CONGENITAL ANOMALY 1 0.0001
405 APNOEA 1 0.0001
406 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
407 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
408 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
409 TRICUSPID VALVE INCOMPETENCE 1 0.0001
410 BLOOD PRESSURE FLUCTUATION 3 0.0001
411 UTERINE CANCER 1 0.0001
412 DRUG INTOLERANCE 12 0.0001
413 SENSORY LOSS 1 0.0001
414 RHINITIS 1 0.0001
415 FRUSTRATION TOLERANCE DECREASED 1 0.0001
416 MUSCLE TIGHTNESS 2 0.0001
417 MUSCLE DISORDER 1 0.0001
418 PRODUCT USE ISSUE 23 0.0001
419 ABNORMAL FAECES 1 0.0001
420 HYPERAESTHESIA 1 0.0001
421 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
422 DRUG LEVEL INCREASED 2 0.0001
423 MUSCLE INJURY 1 0.0001
424 CYTOMEGALOVIRUS INFECTION 2 0.0001
425 COAGULOPATHY 2 0.0001
426 ATRIAL SEPTAL DEFECT 1 0.0001
427 HAEMODIALYSIS 1 0.0001
428 SENSATION OF FOREIGN BODY 1 0.0001
429 HAEMATEMESIS 3 0.0001
430 HEMIPARESIS 2 0.0001
431 VITAMIN D DECREASED 1 0.0001
432 UNRESPONSIVE TO STIMULI 3 0.0001
433 MUSCLE STRAIN 1 0.0001
434 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
435 PYELONEPHRITIS 1 0.0001
436 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
437 LOCAL SWELLING 2 0.0001
438 NAIL DISORDER 1 0.0001
439 CHEST PAIN 21 0.0001
440 LIVER DISORDER 5 0.0001
441 FEELING ABNORMAL 27 0.0001
442 RESPIRATORY RATE INCREASED 1 0.0001
443 GASTROINTESTINAL INFECTION 1 0.0001
444 LIP DRY 1 0.0001
445 OPTIC NEURITIS 1 0.0001
446 EXOSTOSIS 1 0.0001
447 IRON DEFICIENCY ANAEMIA 1 0.0001
448 HYPOKALAEMIA 5 0.0001
449 FEELING COLD 3 0.0001
450 AGRANULOCYTOSIS 2 0.0001
451 CHEST DISCOMFORT 11 0.0001
452 FLANK PAIN 1 0.0001
453 ARTERIOSCLEROSIS 1 0.0001
454 DRUG INEFFECTIVE 140 0.0001
455 ABDOMINAL DISTENSION 11 0.0001
456 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
457 BLOOD PRESSURE INCREASED 16 0.0001
458 PRODUCT SUBSTITUTION ISSUE 6 0.0001
459 DRUG PRESCRIBING ERROR 2 0.0001
460 DIZZINESS POSTURAL 1 0.0001
461 EAR PAIN 2 0.0001
462 VITAMIN D DEFICIENCY 1 0.0001
463 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
464 VISION BLURRED 14 0.0001
465 COELIAC DISEASE 1 0.0001
466 LIGAMENT SPRAIN 1 0.0001
467 CONSTIPATION 22 0.0001
468 HAEMATOCRIT DECREASED 2 0.0001
469 BLADDER DISORDER 1 0.0001
470 INABILITY TO AFFORD MEDICATION 1 0.0001
471 UPPER LIMB FRACTURE 2 0.0001
472 OVARIAN CYST 1 0.0001
473 CARDIAC FAILURE 8 0.0001
474 EMPHYSEMA 1 0.0001
475 VAGINAL DISCHARGE 1 0.0001
476 EYELID PTOSIS 1 0.0001
477 DRY THROAT 1 0.0001
478 DRUG LEVEL DECREASED 1 0.0001
479 BLINDNESS 4 0.0001
480 NEUTROPHIL COUNT DECREASED 4 0.0001
481 MALAISE 43 0.0001
482 INITIAL INSOMNIA 1 0.0001
483 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
484 POOR VENOUS ACCESS 1 0.0001
485 PULMONARY HYPERTENSION 2 0.0001
486 RESPIRATORY FAILURE 7 0.0001
487 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
488 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
489 CARDIO-RESPIRATORY ARREST 4 0.0001
490 WEIGHT FLUCTUATION 1 0.0001
491 SPEECH DISORDER 5 0.0001
492 CEREBROVASCULAR ACCIDENT 16 0.0001
493 DYSGEUSIA 7 0.0001
494 EATING DISORDER 2 0.0001
495 IRRITABLE BOWEL SYNDROME 2 0.0001
496 OESOPHAGITIS 1 0.0001
497 CHOLELITHIASIS 3 0.0001
498 DYSPEPSIA 9 0.0001
499 INJECTION SITE NODULE 1 0.0001
500 EXPIRED PRODUCT ADMINISTERED 3 0.0001
501 RASH MACULO-PAPULAR 2 0.0001
502 IMPAIRED DRIVING ABILITY 1 0.0001
503 CONVULSION 5 0.0001
504 LETHARGY 5 0.0001
505 NEOPLASM PROGRESSION 3 0.0001
506 DYSPHONIA 5 0.0001
507 SURGERY 5 0.0001
508 CARDIAC ARREST 7 0.0001
509 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
510 BACTERAEMIA 1 0.0001
511 COMA 4 0.0001
512 CATARACT 5 0.0001
513 INTERSTITIAL LUNG DISEASE 4 0.0001
514 C-REACTIVE PROTEIN INCREASED 3 0.0001
515 ADRENAL INSUFFICIENCY 1 0.0001
516 PRESYNCOPE 2 0.0001
517 VERTIGO 5 0.0001
518 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
519 OSTEONECROSIS OF JAW 2 0.0001
520 GENERALISED OEDEMA 1 0.0001
521 ILEUS 1 0.0001
522 PNEUMONIA ASPIRATION 2 0.0001
523 INTESTINAL OBSTRUCTION 3 0.0001
524 MUSCLE ATROPHY 1 0.0001
525 DYSPNOEA 44 0.0001
526 INFUSION SITE PAIN 1 0.0001
527 NODULE 1 0.0001
528 ANHEDONIA 2 0.0001
529 ORAL CANDIDIASIS 1 0.0001
530 PULMONARY CONGESTION 1 0.0001
531 ABNORMAL BEHAVIOUR 3 0.0001
532 ADVERSE REACTION 1 0.0001
533 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
534 THROMBOSIS 6 0.0001
535 JOINT RANGE OF MOTION DECREASED 1 0.0001
536 PRODUCT TASTE ABNORMAL 1 0.0001
537 LIMB INJURY 2 0.0001
538 ACUTE HEPATIC FAILURE 1 0.0001
539 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
540 RESPIRATORY ARREST 2 0.0001
541 MENTAL STATUS CHANGES 2 0.0001
542 ASTHENIA 27 0.0001
543 HAEMOPTYSIS 2 0.0001
544 APHONIA 1 0.0001
545 SKIN REACTION 1 0.0001
546 SLEEP DISORDER 5 0.0001
547 PAIN IN JAW 2 0.0001
548 FLATULENCE 4 0.0001
549 SINUS TACHYCARDIA 1 0.0001
550 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
551 RED BLOOD CELL COUNT DECREASED 2 0.0001
552 PARALYSIS 1 0.0001
553 MOBILITY DECREASED 5 0.0001
554 IMPAIRED QUALITY OF LIFE 1 0.0001
555 MYELODYSPLASTIC SYNDROME 1 0.0001
556 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
557 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
558 TACHYCARDIA 6 0.0001
559 OFF LABEL USE 59 0.0001
560 PULMONARY OEDEMA 3 0.0001
561 HAEMORRHAGE INTRACRANIAL 1 0.0001
562 EPISTAXIS 5 0.0001
563 HYPOAESTHESIA ORAL 1 0.0001
564 APHASIA 2 0.0001
565 BLOOD COUNT ABNORMAL 1 0.0001
566 DISCOMFORT 4 0.0001
567 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
568 EMOTIONAL DISORDER 2 0.0001
569 LYMPHOMA 1 0.0001
570 LIMB DISCOMFORT 2 0.0001
571 ANKLE FRACTURE 1 0.0001
572 WEIGHT DECREASED 18 0.0001
573 RENAL DISORDER 3 0.0001
574 SWOLLEN TONGUE 2 0.0001
575 BONE DENSITY DECREASED 2 0.0001
576 BRAIN FOG 1 0.0001
577 CYANOSIS 1 0.0001
578 ARTHRITIS 5 0.0001
579 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
580 NEUROPATHY PERIPHERAL 6 0.0001
581 PNEUMOTHORAX 1 0.0001
582 ULCER 1 0.0001
583 CYSTITIS 2 0.0001
584 HYPOTHYROIDISM 2 0.0001
585 METABOLIC ACIDOSIS 2 0.0001
586 CONDITION AGGRAVATED 19 0.0001
587 BLOOD GLUCOSE DECREASED 3 0.0001
588 MOVEMENT DISORDER 2 0.0001
589 DIZZINESS 31 0.0001
590 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
591 LACTIC ACIDOSIS 2 0.0001
592 BLOOD POTASSIUM INCREASED 1 0.0001
593 DEEP VEIN THROMBOSIS 4 0.0001
594 BACK DISORDER 1 0.0001
595 METASTASES TO BONE 1 0.0001
596 IMPAIRED HEALING 2 0.0001
597 MANIA 1 0.0001
598 PHOTOSENSITIVITY REACTION 1 0.0001
599 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
600 LIP SWELLING 2 0.0001
601 BLOOD UREA INCREASED 1 0.0001
602 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
603 URINARY TRACT INFECTION 10 0.0001
604 HAEMOGLOBIN DECREASED 6 0.0001
605 PERIPHERAL SWELLING 9 0.0001
606 SCAR 1 0.0001
607 ILLNESS 6 0.0001
608 MUSCULOSKELETAL DISCOMFORT 1 0.0001
609 MULTI-ORGAN FAILURE 1 0.0001
610 PAIN IN EXTREMITY 17 0.0001
611 DELIRIUM 2 0.0001
612 MUSCULOSKELETAL PAIN 3 0.0001
613 RASH MACULAR 2 0.0001
614 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
615 LYMPHOCYTE COUNT DECREASED 1 0.0001
616 HEAD DISCOMFORT 1 0.0001
617 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
618 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
619 GASTROINTESTINAL DISORDER 5 0.0001
620 DRUG EFFECT DECREASED 3 0.0001
621 PNEUMONIA 18 0.0001
622 GASTROENTERITIS VIRAL 1 0.0001
623 LEUKOCYTOSIS 1 0.0001
624 RESTLESS LEGS SYNDROME 1 0.0001
625 ACCIDENTAL OVERDOSE 2 0.0001
626 RESTLESSNESS 2 0.0001
627 SOMNOLENCE 11 0.0001
628 TREMOR 9 0.0001
629 MEDICATION ERROR 3 0.0001
630 FATIGUE 42 0.0001
631 CONJUNCTIVITIS 1 0.0001
632 ABDOMINAL DISCOMFORT 9 0.0001
633 MIDDLE INSOMNIA 1 0.0001
634 HYPONATRAEMIA 3 0.0001
635 PHOTOPHOBIA 1 0.0001
636 DYSARTHRIA 2 0.0001
637 DYSPHAGIA 5 0.0001
638 GASTRIC ULCER 1 0.0001
639 GAIT DISTURBANCE 10 0.0001
640 HERPES ZOSTER 3 0.0001
641 PULMONARY FIBROSIS 1 0.0001
642 POST PROCEDURAL COMPLICATION 1 0.0001
643 SEROTONIN SYNDROME 1 0.0001
644 GLAUCOMA 1 0.0001
645 HERNIA 1 0.0001
646 ERUCTATION 1 0.0001
647 PRESCRIBED OVERDOSE 1 0.0001
648 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
649 CHOKING 1 0.0001
650 DISABILITY 1 0.0001
651 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
652 DISORIENTATION 2 0.0001
653 CARDIAC FAILURE CONGESTIVE 4 0.0000
654 PROSTATE CANCER 4 0.0000
655 ILL-DEFINED DISORDER 3 0.0000
656 DYSKINESIA 2 0.0000
657 WEIGHT INCREASED 11 0.0000
658 BODY TEMPERATURE INCREASED 1 0.0000
659 INSOMNIA 13 0.0000
660 RIB FRACTURE 1 0.0000
661 FALL 16 0.0000
662 POLLAKIURIA 2 0.0000
663 DERMATITIS 1 0.0000
664 RENAL IMPAIRMENT 4 0.0000
665 MOUTH ULCERATION 1 0.0000
666 HALLUCINATION, VISUAL 1 0.0000
667 ANAEMIA 9 0.0000
668 OSTEOARTHRITIS 2 0.0000
669 RENAL FAILURE ACUTE 2 0.0000
670 HYPOAESTHESIA 7 0.0000
671 POOR QUALITY SLEEP 1 0.0000
672 BALANCE DISORDER 4 0.0000
673 PRURITUS GENERALISED 1 0.0000
674 AMNESIA 3 0.0000
675 SWELLING FACE 3 0.0000
676 MYOCARDIAL INFARCTION 8 0.0000
677 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
678 DEHYDRATION 6 0.0000
679 NEOPLASM MALIGNANT 3 0.0000
680 GLOSSODYNIA 1 0.0000
681 SNEEZING 1 0.0000
682 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
683 THROAT IRRITATION 2 0.0000
684 THERAPY NON-RESPONDER 2 0.0000
685 CHROMATURIA 1 0.0000
686 MUSCULAR WEAKNESS 5 0.0000
687 NEPHROLITHIASIS 2 0.0000
688 ADVERSE EVENT 4 0.0000
689 CONFUSIONAL STATE 7 0.0000
690 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
691 PERICARDIAL EFFUSION 1 0.0000
692 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
693 OROPHARYNGEAL PAIN 4 0.0000
694 DECREASED APPETITE 10 0.0000
695 BACK PAIN 10 0.0000
696 INJURY 3 0.0000
697 ANXIETY 12 0.0000
698 DIABETIC KETOACIDOSIS 1 0.0000
699 LOCALISED INFECTION 1 0.0000
700 MENTAL IMPAIRMENT 1 0.0000
701 FIBROMYALGIA 1 0.0000
702 UNDERDOSE 3 0.0000
703 PRODUCT DOSE OMISSION ISSUE 12 0.0000
704 ABASIA 1 0.0000
705 VISUAL IMPAIRMENT 5 0.0000
706 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
707 DRY EYE 2 0.0000
708 HYPOTENSION 8 0.0000
709 UNEVALUABLE EVENT 3 0.0000
710 CARDIOVASCULAR DISORDER 1 0.0000
711 DIABETES MELLITUS 3 0.0000
712 FLUSHING 4 0.0000
713 FLUID RETENTION 2 0.0000
714 HYPOPHAGIA 1 0.0000
715 ERECTILE DYSFUNCTION 1 0.0000
716 DIPLOPIA 1 0.0000
717 RESPIRATORY TRACT INFECTION 1 0.0000
718 HAEMORRHAGE 4 0.0000
719 DEAFNESS 1 0.0000
720 ECZEMA 2 0.0000
721 HYPERTENSION 8 0.0000
722 EAR INFECTION 1 0.0000
723 INJECTION SITE HAEMORRHAGE 3 0.0000
724 BREAST CANCER FEMALE 1 0.0000
725 JAUNDICE 1 0.0000
726 RASH PRURITIC 2 0.0000
727 PALLOR 1 0.0000
728 MOOD ALTERED 1 0.0000
729 DRUG DOSE OMISSION 6 0.0000
730 HAEMATOCHEZIA 2 0.0000
731 RESPIRATORY DISTRESS 1 0.0000
732 ABNORMAL DREAMS 1 0.0000
733 ANAPHYLACTIC REACTION 2 0.0000
734 DIVERTICULITIS 1 0.0000
735 ARTHROPATHY 2 0.0000
736 INFLUENZA 4 0.0000
737 SEPSIS 4 0.0000
738 NECK PAIN 2 0.0000
739 DEMENTIA 1 0.0000
740 THROMBOCYTOPENIA 4 0.0000
741 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
742 EYE PAIN 2 0.0000
743 ASTHMA 4 0.0000
744 MYALGIA 6 0.0000
745 INTENTIONAL DOSE OMISSION 1 0.0000
746 ANGINA PECTORIS 1 0.0000
747 HYPERSOMNIA 1 0.0000
748 EYE IRRITATION 2 0.0000
749 LIVER FUNCTION TEST ABNORMAL 1 0.0000
750 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
751 COVID-19 6 0.0000
752 BONE PAIN 2 0.0000
753 CHILLS 4 0.0000
754 ASCITES 1 0.0000
755 ABDOMINAL PAIN UPPER 7 0.0000
756 ACUTE MYOCARDIAL INFARCTION 1 0.0000
757 LABORATORY TEST ABNORMAL 1 0.0000
758 RESPIRATORY DISORDER 1 0.0000
759 BLOOD POTASSIUM DECREASED 1 0.0000
760 LACRIMATION INCREASED 1 0.0000
761 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
762 THERAPEUTIC RESPONSE DECREASED 2 0.0000
763 PLEURAL EFFUSION 2 0.0000
764 OEDEMA PERIPHERAL 4 0.0000
765 FEELING HOT 2 0.0000
766 BREAST CANCER 3 0.0000
767 PARAESTHESIA 5 0.0000
768 PULMONARY EMBOLISM 3 0.0000
769 NIGHT SWEATS 1 0.0000
770 OSTEONECROSIS 1 0.0000
771 STAPHYLOCOCCAL INFECTION 1 0.0000
772 FEBRILE NEUTROPENIA 2 0.0000
773 RENAL FAILURE 4 0.0000
774 VISUAL ACUITY REDUCED 1 0.0000
775 ABDOMINAL PAIN 7 0.0000
776 FUNGAL INFECTION 1 0.0000
777 GAIT INABILITY 1 0.0000
778 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
779 ANGER 1 0.0000
780 SINUSITIS 3 0.0000
781 HAEMATURIA 1 0.0000
782 MEMORY IMPAIRMENT 4 0.0000
783 HYPERKALAEMIA 1 0.0000
784 DEVICE MALFUNCTION 2 0.0000
785 HYPOXIA 1 0.0000
786 PLATELET COUNT DECREASED 3 0.0000
787 PRODUCT ADHESION ISSUE 1 0.0000
788 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
789 CEREBRAL HAEMORRHAGE 1 0.0000
790 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
791 RASH 12 0.0000
792 CRYING 1 0.0000
793 HYPERGLYCAEMIA 1 0.0000
794 PANIC ATTACK 1 0.0000
795 HEADACHE 17 0.0000
796 INJECTION SITE MASS 1 0.0000
797 BRONCHITIS 2 0.0000
798 EYE SWELLING 1 0.0000
799 BLOOD GLUCOSE INCREASED 5 0.0000
800 INCORRECT DOSE ADMINISTERED 6 0.0000
801 HOSPITALISATION 4 0.0000
802 NAUSEA 20 0.0000
803 COUGH 7 0.0000
804 JOINT SWELLING 3 0.0000
805 DIARRHOEA 16 0.0000
806 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
807 LUNG NEOPLASM MALIGNANT 1 0.0000
808 COMPLETED SUICIDE 2 0.0000
809 ROAD TRAFFIC ACCIDENT 1 0.0000
810 WITHDRAWAL SYNDROME 1 0.0000
811 TOXICITY TO VARIOUS AGENTS 4 0.0000
812 PRURITUS 9 0.0000
813 HYPERHIDROSIS 3 0.0000
814 VAGINAL HAEMORRHAGE 1 0.0000
815 MENTAL DISORDER 1 0.0000
816 PAIN 14 0.0000
817 ADVERSE DRUG REACTION 2 0.0000
818 NEUTROPENIA 3 0.0000
819 DEPRESSION 5 0.0000
820 SKIN IRRITATION 1 0.0000
821 COGNITIVE DISORDER 1 0.0000
822 VOMITING 10 0.0000
823 COLORECTAL CANCER 1 0.0000
824 PRODUCTIVE COUGH 1 0.0000
825 RASH ERYTHEMATOUS 1 0.0000
826 MULTIPLE SCLEROSIS 1 0.0000
827 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
828 CONTUSION 2 0.0000
829 ALOPECIA 4 0.0000
830 LEUKOPENIA 1 0.0000
831 CELLULITIS 1 0.0000
832 INFLAMMATION 1 0.0000
833 ARTHRALGIA 8 0.0000
834 DRUG DEPENDENCE 3 0.0000
835 OVERDOSE 4 0.0000
836 TREATMENT NONCOMPLIANCE 1 0.0000
837 BLISTER 1 0.0000
838 OXYGEN SATURATION DECREASED 1 0.0000
839 DEATH 15 0.0000
840 PYREXIA 6 0.0000
841 NASAL CONGESTION 1 0.0000
842 IRRITABILITY 1 0.0000
843 SUICIDE ATTEMPT 1 0.0000
844 STOMATITIS 1 0.0000
845 NASOPHARYNGITIS 3 0.0000
846 HYPERSENSITIVITY 3 0.0000
847 INJECTION SITE ERYTHEMA 2 0.0000
848 INTENTIONAL OVERDOSE 1 0.0000
849 PRODUCT DOSE OMISSION 1 0.0000
850 BLOOD CREATININE INCREASED 1 0.0000
851 INJECTION SITE PRURITUS 1 0.0000
852 HEPATIC ENZYME INCREASED 1 0.0000
853 BURNING SENSATION 1 0.0000
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
855 THERAPY INTERRUPTED 1 0.0000
856 INFECTION 2 0.0000
857 AGITATION 1 0.0000
858 HALLUCINATION 1 0.0000
859 HOT FLUSH 1 0.0000
860 ACUTE KIDNEY INJURY 2 0.0000
861 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
862 MUSCULOSKELETAL STIFFNESS 1 0.0000
863 DEVICE ISSUE 1 0.0000
864 SWELLING 1 0.0000
865 MIGRAINE 1 0.0000
866 ERYTHEMA 2 0.0000
867 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
868 RHEUMATOID ARTHRITIS 1 0.0000
869 SEIZURE 1 0.0000
870 DISEASE PROGRESSION 1 0.0000
871 EMOTIONAL DISTRESS 1 0.0000
872 DRY SKIN 1 0.0000
873 INJECTION SITE PAIN 2 0.0000
874 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
875 NO ADVERSE EVENT 1 0.0000
876 MUSCLE SPASMS 1 0.0000